Yahoo · Oct 30, 2026
How This Under-the-Radar Quantum Stock Could More Than Double
Pasqal’s neutral-atom architecture and practical commercial road map will drive massive upside, Cantor Fitzgerald says.
NASDAQ · IBM
International Business Machines Corporation
Technology · Information Technology Services
$257.81
Down-$0.47 (-0.18%)
Updated Oct 31, 2026, 3:29 AM
SID Score
6.9/10
Composite research score
Smart Money
61/100
Neutral
- Market cap
- 290.29B
- P/E ratio
- 36.68
- Dividend yield
- 2.60%
- 52-week range
- $199.19 – $332.46
- Volume
- 5.74M
- Avg. volume
- 5.25M
Price performance · IBM
IBM price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
IBM closed at $257.81 after 21 trading sessions, up 15.80% for the selected period.
- Last close
- $257.81
- Period change
- +15.80%
- Period low
- $220.51
- Period high
- $258.28
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $258.28 | $259.59 | $254.7105 | $257.81 | 5.74M |
| Oct 29, 2026 | $249.27 | $258.33 | $247.8001 | $258.28 | 3.93M |
| Oct 28, 2026 | $248.49 | $253.85 | $247.67 | $253.22 | 3.71M |
| Oct 27, 2026 | $251.9325 | $253.18 | $249.125 | $250.25 | 3.66M |
| Oct 26, 2026 | $253.01 | $256.00 | $250.80 | $253.44 | 3.75M |
| Oct 23, 2026 | $249.73 | $254.71 | $247.03 | $253.56 | 5.89M |
| Oct 22, 2026 | $241.245 | $256.30 | $240.00 | $252.11 | 11.63M |
| Oct 21, 2026 | $241.915 | $251.75 | $240.62 | $251.46 | 10.03M |
| Oct 20, 2026 | $236.08 | $242.525 | $236.00 | $241.92 | 5.75M |
| Oct 19, 2026 | $230.68 | $238.38 | $229.2965 | $236.39 | 4.91M |
| Oct 16, 2026 | $236.05 | $236.98 | $230.25 | $232.14 | 6.96M |
| Oct 15, 2026 | $226.36 | $234.14 | $226.01 | $234.12 | 5.6M |
| Oct 14, 2026 | $231.13 | $233.14 | $227.49 | $227.88 | 4.05M |
| Oct 13, 2026 | $228.215 | $233.50 | $227.277 | $230.78 | 5.12M |
| Oct 12, 2026 | $228.31 | $229.285 | $224.77 | $227.02 | 2.76M |
| Oct 9, 2026 | $225.87 | $228.76 | $224.0501 | $227.13 | 3.35M |
| Oct 8, 2026 | $220.15 | $227.305 | $217.795 | $226.61 | 8.93M |
| Oct 7, 2026 | $221.90 | $222.41 | $218.79 | $220.51 | 3.9M |
| Oct 6, 2026 | $222.71 | $224.51 | $221.00 | $221.29 | 3.94M |
| Oct 5, 2026 | $222.30 | $222.88 | $220.30 | $221.58 | 6.32M |
| Oct 2, 2026 | $225.51 | $225.915 | $221.63 | $222.64 | 7.76M |
Latest IBM news
The latest Smart Investors Daily articles mentioning IBM.
Stock researchCompany · Overview
Company
Market Activity
Research & News
IBM research
Overview
Company profile and research snapshot.
Company profile
Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world. It provides software, IT consulting services, and hardware to help business customers modernize their technology workflows. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which includes 95% of all Fortune 500 companies. IBM's products, including Red Hat, watsonx, and mainframes, handle some of the world's most important data workloads in areas like finance and retail.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $293.86
- Implied upside
- —
- Analysts
- 18
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 22, 2026 | Stifel | Buy | — |
| Oct 22, 2026 | JP Morgan | Overweight | — |
| Oct 22, 2026 | Susquehanna | Neutral | — |
| Oct 22, 2026 | Baird | Neutral | — |
| Oct 22, 2026 | Jefferies | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 30, 2026
Global Clinical Knowledge Graphs for Genomics Market Report 2026 | Capitalize on 20.7% CAGR as Microsoft, IBM, Illumina and Genomenon Scale AI, Cloud and Precision Medicine
Boost ROI with cloud-based AI, genomic data integration, variant interpretation, predictive analytics and custom knowledge modeling for precision medicine and drug discovery.Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Clinical Knowledge Graphs for Genomics Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global clinical knowledge graphs for genomics market is experiencing rapid expansion as healthcare providers, researchers, and life sciences organizations seek
Yahoo · Oct 30, 2026
Why Should You Pay Attention To QBTS Stock?
For questions about this article or underlying research, email [email protected].
Yahoo · Oct 30, 2026
Can Accenture Stock Rise 30% From Here?
For questions about this article or underlying research, email [email protected].
AI research layers
Interpretive context generated from the platform’s current data sources.
IBM Stock Performance
International Business Machines Corporation shares closed at $258.28, reflecting a single-day decline of approximately 1.10%, per SID market data. Despite the session's pullback, IBM has demonstrated strong near-term momentum, gaining 15.11% over the past month and 14.20% over the trailing three months, according to Massive/Polygon data. However, the stock has declined 14.15% on a one-year basis, indicating that the recent rally represents a recovery from a prior downturn rather than sustained upward momentum. Technically, IBM trades well above its 50-day moving average of $234.26 and its 200-day moving average of $244.56, signaling a bullish trend structure. The 14-day relative strength index stands at 80.8, placing the stock firmly in overbought territory. IBM carries a beta of 0.689, indicating lower volatility relative to the broader market. Average daily trading volume stands at approximately 5.25 million shares, per SID market data.
IBM Valuation Analysis
International Business Machines Corporation carries a market capitalization of approximately $290.3 billion, positioning it among the largest technology firms globally, per SID market data. The stock trades at a price-to-earnings ratio of 36.68, a premium multiple that reflects elevated investor expectations for the company's hybrid cloud and AI-driven growth initiatives. The PEG ratio stands at 1.03, suggesting that the current P/E multiple is roughly in line with projected earnings growth rates, according to SEC filings and consensus estimates. IBM's price-to-book ratio of 10.39 indicates the market values the company at more than ten times its book equity, a figure consistent with asset-light, software-oriented business models. The company maintains a dividend yield of 2.16%, providing income-oriented investors with a steady return component. Within the technology sector, IBM's valuation profile reflects its ongoing strategic transformation toward higher-margin recurring revenue streams.
Smart Money Activity for IBM
International Business Machines Corporation registers a smart money composite score of 61 out of 100 with a neutral overall signal, per SID market data. The institutional component scores a perfect 25 out of 25, reflecting strong and consistent positioning by large asset managers in IBM shares. In contrast, insider activity scores 13.2 out of 25, though recent transaction data reveals a notably bullish tilt: SEC Form 4 filings show 14 insider trades over the past 90 days, of which 13 were purchases and only one was a sale. This buy-to-sell ratio suggests corporate insiders have demonstrated meaningful confidence in the stock at recent price levels. Dark pool activity scores 12.2 out of 25, indicating moderate institutional block trading interest, while congressional trading activity registers at 10.7 out of 25, per 13F institutional filings. The divergence between maximum institutional conviction and more moderate signals across other channels accounts for the neutral composite reading despite the overwhelmingly positive insider purchase pattern.
IBM Earnings Outlook
International Business Machines Corporation has delivered a mixed but generally positive earnings trajectory across its last four reported quarters, per company earnings reports. The most recent quarter posted earnings per share of $2.95 against an analyst consensus estimate of $2.87, representing a positive surprise of $0.08. In the prior quarter, IBM reported EPS of $2.93, missing the $3.02 estimate by $0.09, marking the sole shortfall in the four-quarter span. The company delivered its strongest beat two quarters earlier, reporting $4.52 per share versus estimates of $4.31, a $0.21 upside surprise. The quarter before that saw EPS of $1.91 against a $1.81 estimate, a $0.10 positive surprise. Across the four periods, IBM exceeded analyst expectations in three out of four quarters, per analyst estimates. The pattern of predominantly positive surprises suggests the company's operational execution has largely met or surpassed Wall Street forecasts during this period.
Wall Street Analyst Ratings for IBM
Wall Street coverage of International Business Machines Corporation reflects a moderately constructive outlook, according to the most recent analyst reports dated October 22, 2026. Among five tracked firms issuing updated ratings, two maintained bullish stances: Stifel reiterated its Buy rating and Jefferies also reiterated Buy, per SID consensus data. JP Morgan maintained its Overweight rating, providing a third constructive signal among the coverage group. On the other side, both Susquehanna and Baird reiterated Neutral ratings, reflecting a more cautious view of IBM's risk-reward profile at current valuation levels. Notably, none of the five analysts changed their prior ratings, indicating a stable consensus view rather than any directional shift in sentiment. The split of three bullish ratings against two neutral ratings suggests the analyst community broadly favors IBM but acknowledges limited near-term catalysts for further multiple expansion given the stock's elevated RSI and trailing P/E ratio of 36.68, per Wall Street analyst reports.
